Process for the preparation of S-fluoromethyl-6,9-difluoro-11-hydroxy-16-methyl-17-propionyloxy-3-oxo-androsta-1, 4-diene-17-carbothioate and intermediates
AU2013202833A1
A process for the preparation of enantiomerically pure amines
AU2013200937A1
Polymorphic forms of bosentan
AU2011294906A1
Pure intermediate for preparing letrozole
CN103124557A
Pure erlotinib
NZ604011A
Crystalline forms of thalidomide and processes for their preparation
NZ603653A
Processes for the preparation of dipyridamole
WO2011086541A1
Novel polymorph of nilotinib monohydrochloride monohydrate
WO2011104540A1
One step process for the preparation of capecitabine
WO2011095800A2
Analytical methods
WO2011095802A1
Hplc method for analyzing sunitinib
WO2011095803A1
Hplc method for analyzing frovatriptan
WO2011067588A1
Cyclic sulphinyl esters of cytidine
WO2011061545A1
Hplc method for analyzing vorinostat
WO2011033307A1
Nilotinib dihydrochloride salt
WO2011015884A1
Process to prepare scopine esters
NZ597920A
Anhydrate of tiotropium bromide
WO2011015883A1
Dichloromethane solvate of tiotropium bromide and its use